Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Harriet
Harriet Chan-Myers, Lake Forest, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090111895 | ENHANCED DIALDEHYDE DISINFECTANT AND STERILIZATION FORMULATIONS - High-level disinfectant formulations and sporicidal formulations suitable for use as chemical disinfection and sterilization mediums comprising a dialdehyde, a carboxylate salt in amount of from about 3 weight percent to about 20 weight percent, and the balance water. The formulations are useful for disinfecting and sterilizing medical instruments and medical equipment. | 04-30-2009 |
Harriet Ronnholm, Trangsund SE
| Patent application number | Description | Published |
|---|---|---|
| 20080213276 | Modulation of neural stem cells and neural progenitor cells - The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via S1P or LPA signaling. These methods are useful for reducing at least one symptom of the disorder. | 09-04-2008 |
| 20090232775 | Compounds and methods for increasing neurogenesis - The invention is directed to methods of promoting neurogenesis by contacting neuronal tissue with neurogenesis modulating agents. Novel methods for treating neurological disorders using neurogenesis modulating agents are disclosed. | 09-17-2009 |
Harriet Rönnholm, Trangsund SE
| Patent application number | Description | Published |
|---|---|---|
| 20110189184 | MODULATION OF NEURAL STEM CELLS AND NEURAL PROGENITOR CELLS - The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via S1P or LPA signaling. These methods are useful for reducing at least one symptom of the disorder. | 08-04-2011 |
Harriet Wikman-Kocher, Hamburg DK
| Patent application number | Description | Published |
|---|---|---|
| 20100279281 | METHOD OF IDENTIFYING LUNG CANCERS ASSOCIATED WITH ASBESTOS-EXPOSURE - The present invention is related to a method for assessing the presence of, or disposition to, an asbestos-related disorder in a subject. Particularly, the invention provides a method of identifying lung cancers associated with asbestos-exposure. The association is confirmed by the detection of allelic imbalance (AI) in at least one of the following chromosomal regions of lung cancer cells: 19p13.3-p13.1; 9q32-34.3; 2p21-p16.3; 16p13.3; 22q12.3-q13.1; and 5q35.3. | 11-04-2010 |